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CLINICAL INVESTIGATION
Increased Na/H antiport activity and abundance in uremic red
blood cells
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Increased Na/H antiport activity and abundance in uremic red blood
cells. Alterations in red blood cell sodium (Na) transport have been
described in chronic renal failure. This study examines the possible
impact of uremia on two ouabain-insensitive pathways, the Na/H
antiporter and the C1/NaCO3 anion exchanger. The Vm of Na/H
antiporter measured as Na influx driven by outward H gradient in acid
loaded red blood cells was significantly higher in uremic red blood cells
versus controls (60.5 16.5 vs. 24.5 5.4 mmollliter cells/hr, P <
0.025). This increase in activity was associated with an increased
abundance of the Na/H antiporter as determined by immunologic
analysis using an affinity purified polyclonal antibody to the human
NHE-l isoform of the antiporter. By contrast, the activity of the anion
exchanger measured as the DIDS-sensitive lithium (Li) influx was
similar in uremic versus control red blood cells (2.10 0.18 vs. 2.14
0.20 mmol/liter cells/hr). These experiments, when considered in con-
junction with prior studies showing normal Na/Li countertransport in
uremia indicate that there is a selective increase in the number of
functional Na/H antiporters in uremic red blood cells and that Na/Li
countertransport measurements may not be a valid marker for Na/H
antiporter activity in red blood cells in patients requiring dialysis for
end-stage renal failure.
The activity of selected transporters present in human red
blood cells has been measured previously in order to under-
stand the consequences of the altered metabolic profile of
patients with renal failure [1, 3]. The activity of a presumed
surrogate marker for the Na/H antiporter, Na/Li countertrans-
port, has been determined in patients with renal failure requir-
ing hemodialysis and was found to be normal [2, 3]. Na/H
exchange activity in red blood cells of such patients, however,
has not previously been reported. In the present study, Na/H
cation exchange activities were measured in red blood cells of a
group of stable end-stage renal disease patients on hemodialy-
sis. In addition, abundance of the "housekeeping" form of the
Na/H antiporter (NHE-l) was determined using a polyclonal
antibody to a synthetic peptide representing NHE- 1. The activ-
ity of the DIDS sensitive anion exchanger was also measured.
This transporter increases the carbon dioxide carrying capacity
of the blood by exchanging Cl— for HC03 and accounts for
approximately 50% of Na influx into red blood cells under
physiologic conditions. The results indicate an increase in the
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Vma.i of the Na/H antiporter in red blood cells from these
patients and an increase in the abundance of NHE-l or a related
isoform. By contrast, the activity of the Na-dependent DIDS
sensitive anion exchanger transporter was not different between
the groups.
Methods
Subjects
Transport studies were performed in red blood cells obtained
from eleven Caucasian male subjects and one female subject
with end-stage renal failure receiving chronic maintenance
hemodialysis. The age range of this population was 46 to 65
years (mean SEM 56.6 1.7). The etiologies of the renal
failure and the number of patients (in parentheses) were as
follows: chronic glomerulonephritis (5), diabetic nephropathy
(4), polycystic kidney disease (2), and light chain disease (1).
Patients received three, four hour bicarbonate dialysis weekly
and were dialyzed against a bath with the following composition
(mEq/liter): sodium 135, calcium 3.5, potassium 2, magnesium
0.75, chloride 105, bicarbonate 35 and dextrose 2 g/liter. The
normal control population consisted of 11 Caucasian males and
one female with an age range from 27 to 57 years (mean SEM
38 2.2). All control subjects had normal renal function and no
significant medical problems. Due to changes in the patients
condition, death, renal transplantation, and/or movement out of
the area only four patients and five control subjects were
available when the antibody to NHE-1 was developed. Red
blood cell samples were obtained from an additional eight
patients and three controls for performance of the quantitative
immunoblots. The characteristics of these additional subjects
was similar to those of the original group noted above.
Red blood cell Na/H antiporter
The activity of Na/H antiporter was measured as the Na
influx driven by an outward H gradient in red blood cells
Na-depleted and acid-loaded according to the method described
by Semplicini, Spalvins and Canessa [4]. After obtaining in-
formed consent, fresh venous blood was drawn between 08:00
and 10:00 hours in control subjects and in patients before
starting dialysis. Blood was collected into heparinized tubes
and the plasma and buffy coat discarded after separation by a 10
minute centrifugation at 1,750 g. The packed cells were washed
four times in a choline washing solution. The red blood cells
were used the same day. The nystatin loading procedure
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described by Cass and Dalmark [5] and modified by Canessa et
a! [61 was used to reduce the red blood cell Na1 below 1
mmol/liter cell. The pH of Na-depleted red blood cells was
modified by incubating the cells for 10 minutes at 37°C in a
solution containing (mM): 10 glucose, 0.15 MgCI2, 0.1 ouabain,
0.01 bumetanide, 20 Tris-Mes (2 [N-morpholino] ethane sul-
fonic acid) (pH 5.6 at 37°C), 40 sucrose. The pH1 was clamped
by addition of 0.2 mmollliter of DIDS and 0.5 mmol/liter metha-
zolamide. The cells were then incubated for 30 minutes at 37°C
in their respective solutions. Red blood cells were prepared
with pH1 at 5.8, 6.2, 6.5, 6.7, 6.8 and 7.2. The acid loaded red
blood cells were washed four times with cold unbuffered
washing solutions. The pH1 of red blood cells was measured by
the lysis technique [71 using 0.2 ml of packed red blood cells in
2 ml of 0.02% acationox detergent and the pH of the lysate
measured with an Orion Research 940 pH meter at room
temperature (Orion Research Inc., Cambridge, Massachusetts,
USA). Aliquots of 50 d of the cell suspensions were taken to
measure hematocrit (Hct) and hemoglobin (Hb). The pH of
lysate from fresh red blood cells was also measured. Initial rates
of Na influx were measured in acid-loaded red blood cells
suspended at 1% Hct. The Na media contained (mM): 150 NaCI,
10 glucose, 40 sucrose, 0.15 MgCl2, 0.1 ouabain, 0.01 bumet-
anide, 0.5 methazolamide, 10 Tris-Mops (pH 8 at 37°C) or
Tris-Mes (pH 6 at 37°C). The transport reaction was stopped
after 1, 6 and 11 minutes by pipetting triplicate aliquots of 0.2 ml
of cell suspension into Eppendorf tubes containing 0.7 ml of
cold Na-free solution layered over debutylphthalate. The tubes
were spun at 12,000 g for 15 seconds, the supernatant aspirated
and the bottom of the tubes cut into tubes containing acationox
0.02%. Fifty microliter of the lysate was diluted 1/10 to measure
Hb. The Na concentration of the lysate was measured by
atomic absorption spectrophotometry using Na standards. The
red blood cell Na concentration was calculated according to a
standard equation [4].
Na/H exchange was calculated by subtracting the Na influx in
pH 6.0 medium from that in pH 8 and expressed in mmol/liter
cell/hr. The assay reproducibility is 12%. Because of inter-
individual variations in the normal population, assays were
always run in pairs using red blood cells from patients and
controls.
Expression of the Na/H antiporter protein
Antibody generation. Expression of the red blood cell Na/H
antiporter was measured using a monospecific polyclonal anti-
body to the cloned human Na/H antiporter. This antibody was
prepared using a synthetic peptide to amino acids 759 to 769; a
putative inner cytosolic domain of NHE-l [8]. This peptide was
synthesized with an added N terminal cysteine and coupled to
keyhole limpet hemocyanin using M-maleimidobenzoyl-N-hy-
droxysuccinimide. The peptide was emulsified in complete
Freund's adjuvant and injected subcutaneously into rabbits.
Booster injections with the conjugated synthetic peptide emul-
sified in incomplete Freund's adjuvant were administered at
intervals of 10 to 30 days. The immunoglobulin fraction from
rabbit serum was partially purified by repeated precipitations
with 50% saturated ammonium sulfate and chromatography on
DEAE AffiGel Blue to remove residual serum albumin and
trace serum protease activity. Affinity purified antibodies were
prepared by chromatography on AffiGel-lO coupled to the
original peptide using 3 M sodium thiocyanide. The affinity
column purified immunoglobulin fraction was dialyzed exten-
sively against water to remove traces of cyanide. This antibody
has been characterized in a prior publication from these labo-
ratories [9]. In brief, this synthetic peptide antibody recognizes
a single band in human red blood cell of approximate molecular
weight of 105 kDa. Recognition of this band is blocked com-
pletely by preabsorption of the antibody with its antigen.
Pre-immune sera contained no antibodies to the 105 kDa
protein.
Red blood cell membrane preparation
Red blood cell membrane ghosts were prepared using a
modification of the technique of Preiss et al [10]. The cells were
washed three times with 130 m choline chloride solution and
hemolyzed for 30 minutes in a lysing solution containing
NaHCO3, 3.08 NaC1, 0.1 EDTA and Tris HC1, pH 7.8 at 4°C.
The red blood cell membranes were separated by centrifugation
at 17,000 rpm for 30 minutes and then washed twice with aS mM
Tris-Mops and 0.1 EDTA solution, pH 7.4. The membrane
pellets were resuspended in 2% sodium dodecyl with 2%
mercapto-ethanol. Aliquots were taken for protein quantifica-
tion and the remainder was solubilized by boiling for two
minutes. The samples were stored at —80°C for later use.
Protein concentrations were determined by the method of
Lowry et al [11].
Western immunoblots
Western immunoblot analysis was performed by a modifica-
tion of the method of Towbin, Stachlein and Gordon [12]. Equal
amounts (10 g) of red blood cell membrane proteins from eight
controls and 12 hemodialyzed patients were separated onto a
10% SDS polyacrylamide gel and transferred by electrophoresis
to nitrocellulose. The nitrocellulose was blocked with 5%
bovine serum albumin (BSA) in phosphate buffered saline
containing 0.1% Tween-20 (PBST) for four hours before react-
ing with the antisera overnight at 4°C. Immune complexes were
detected by the addition of 1251 labeled staphylococcus aureus
protein A (106 cpmlml) for 30 minutes at room temperature. The
nitrocellulose filters were then washed with PBST and visual-
ized by autoradiography. All gels were loaded with the same
initial amount of red blood cell protein. Any given gel had six to
eight lanes and contained samples from both patients and
controls. The equality of the loading was confirmed by inspec-
tion of the protein stained SDS slab gels. Autoradiographs were
quantitated using laser densitometry. The densitometer was
blanked using the same area of each lane which did not contain
bands. These readings were very constant in individual gels.
Preliminary studies indicated that the amount of NHE- I protein
contained on the gels was in the linear range of the relation
between protein concentration and densitometry readings.
C1/NaCO3 anion exchanger
The activity of the anion exchange carrier was measured as
the DIDS-(4,4 diisothiocyanostilbene-2-2-disulfonate) sensitive
influx of Li into fresh red blood cells incubated in a Li2CO3
medium, according to a method described by Garay et a! [13].
Packed red blood cells were washed twice with cold 150
mmol/liter NaC1 and resuspended to a hematocrit (Hct) of 3%.
For each sample, 0.5 ml of cell suspension was added to
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duplicate tubes containing 2 ml of Li2CO3 medium with and
without 20 mmoL1liter DIDS. The Li2CO3 medium contained
(mM): 20 Li2CO3 112 NaCI, 0.8 CaCI2, 0.8 MgCI2, 0.08 ouabain,
10 glucose, 8 Tris-Mops (Tris [hydroxymethyl] aminomethane;
MOPS, 4-morpholino-propane, sulfonic acid) (pH 7.4 at 37°C).
The capped tubes were either left on ice for one minute and
centrifuged immediately or incubated for 90 minutes at 37°C.
The reaction was stopped by rapid cooling of the tubes at 4°C
for one minute followed by centrifugation for four minutes at
1,750 g at 4°C. The supernatants were carefully removed and
the pellets were rapidly washed three times with 150 mrvi NaC1.
The red blood cell pellets were then hemolyzed with 2 ml of
0.02% acationox detergent. After 10 minutes of centrifugation,
the supernatants were transferred in plastic tubes for hemoglo-
bin (Hb) optical density determination using a Gilford spectro-
photometer as well as Li measurements on a Perkin-Elmer
atomic absorption spectrophotometer against Li standards. Li
influx was calculated from the difference in Li influx between
the tubes with and without DIDS. Results were expressed in
mmollliter cell/hr.
Statistical analysis
All data are reported as mean SEM. Statistical significance
was determined using unpaired Student's f-test and analysis of
variance. The null hypothesis was rejected when the P value
was less than 0.05.
Results
Intracellular concentrations of Na
The Na concentration in fresh red blood cells from dialysis
patients (N = 12) was similar to control subjects (N = 12) and
averaged 8.08 0.48 versus 8.34 0.56 mmol/liter cells,
respectively. After nystatin K-loading, mean [Na1] also was not
different in patients (0.74 0.09 mmol/liter cells) compared to
control (0.81 0.09). Mean pH1 was similar in uremic red blood
cells and in controls (7.230 0.030, N = 10 and 7.240 0.030,
N = 11, respectively).
Na/H ant iporter
Figure 1 shows the mean levels of Na influx at Vmax and
Figure 2 shows the pH activation curves in acid-loaded red
blood cells for Na influx through the Na/H antiporter. Mean Na
influx at max was 60.5 16.5 mmol/liter cell/hr in uremic red
blood cells compared to 24.5 5.4 in control red blood cells (P
< 0.025). Kinetic analysis performed by Hill plot yielded a
similar mean pK in uremic red blood cells compared to controls
(6.58 0.10 vs. 6.55 0.15) and similar values for the N
apparent (2.32 0.20 vs. 2.46 0.30).
Protein abundance
Figure 3 depicts Na/H antiporter abundance as determined by
quantitative immunoblots and expressed as arbitrary units.
Mean values obtained in uremic red blood cells were signifi-
cantly higher than in controls (58.9 9.50 vs. 37.90 7.50, P
<0.05). When abundance of the Na/H antiporter protein and
Na influx rates were measured in the same individuals, a strong
positive correlation (r = 0.90) was found between Vm, of the
transporter and its abundance regardless of renal function (Fig. 4).
Fig. 1. Mean SEM levels of Na/H ant iport (measured as Na influx) in
red blood cells from control and dialysis subjects (P < 0.025).
C1/NaCO3 anion exchange
Mean values for DIDS-sensitive LiCO influx measured in
dialysis patients (2.10 0.18 mmol/liter cells/hr) were not
different from those measured in controls (2.14 0.20).
Discussion
Renal failure results in alterations in the function of cells [1].
In an attempt to understand the pathogenesis of aspects of the
uremic syndrome, a number of investigators have assayed
selected electrolyte transport mechanisms in red blood cells of
patients with chronic renal failure [2, 3]. Such studies, however,
have not provided a definitive picture. For example, the steady
state sodium concentration in red blood cells of patients with
uremia has been reported to be high [141, low, [15—18] and
normal [2, 3] in various studies. In like manner, there is no
consensus on whether or not there is an alteration in the activity
of Na/K ATPase in red blood cells of patients with advanced
renal insufficiency [1]. The present experiments were under-
taken to examine the activity of the Na/H antiporter and
Na-dependent anion exchanger in red blood cells of stable renal
failure patients requiring hemodialysis. By contrast to other red
blood cell transporters, these two sodium influx pathways have
not been studied in detail in uremia. In addition, the develop-
ment of a monospecific antibody to a Na/H antiporter present in
red blood cells provided the opportunity to study the kinetics of
this transporter.
The results of the present experiments indicate that the Vmax
but not the affinity (pK) of the Na/H antiporter in red blood cells
of patients requiring hemodialysis is increased almost twofold
as compared to controls. To our knowledge, this is the first
demonstration of an increase in the activity of this transporter
in human red blood cells in uremia. By contrast, the activity of
the Na-dependent DIDS-sensitive anion exchanger was not
altered. Prior studies from this laboratory in a similar popula-
tion of patients have indicated that Na/K ATPase activity was
I
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Fig. 3. Na/H antiporter abundance measured in arbitrary units in red
blood cells from 8 controls and 12 patients (P < 0.05).
normal in red blood cells [19]. Thus, it would appear that the
increase in the activity of the NaJH antiporter is relatively
selective and is not the consequence of general cell dysfunction
in renal insufficiency.
An increase in max of a transport system suggests an
increase in either the number of transport units or their rate of
turnover. In the present experiments, these possibilities were
examined using quantitative immunologic techniques. Sardet
and co-workers reported recently the structure of a human
Na/H antiporter (NHE-l) which is widely distributed in tissues
[8]. This transporter appears to function in defense of cell pH
and cell volume, and may be involved in the response of some
cells to mitogenic stimuli [20]. An affinity-purified monospecific
25 50 75 100
Protein expression, arbitrary units
Fig. 4. Relationship between Na/H antiporter activity (Na influx at
V,,,..) and protein abundance in red blood cells from subjects on
dialysis (•) and controls (0) (r = 0.90, p < 0.001).
antibody to a synthetic peptide representing a putative internal
cytosolic domain of NHE-l was developed in rabbits. The
antibody recognizes a band of approximately 105 kDa in human
red blood cells. Pre-immune sera does not contain antibodies
reactive with this protein and recognition of the 105 kDa band is
blocked completely by pre-absorption of the antibody with its
peptide antigen. In other preliminary studies, an antibody to a
synthetic peptide representing a putative non-cystosolic ex-
tramembraneous domain of NHE-l also recognized a protein
band of the same size in human red blood cells [9]. It would
appear, then, that human red blood cells express NHE- 1 or an
immunologically closely related isoform. As determined by
quantitative Western immunoblot analysis, uremic red blood
cells have an absolute increase in the number of immunologi-
cally recognized NHE-l transporters. The magnitude of the
increase approximated the magnitude of the increase in the
Vmax of the Na/H antiporter. In addition, in patients and
controls in whom transport rates were measured and Western
immunoblots performed, there was a significant correlation
between the Vmax of the Na/H antiporter and the abundance of
NHE-1. Taken together, these results are consistent with the
conclusion that there is an absolute increase in the number of
functional Na/H antiporters in red blood cells of patients with
A Control B Dialysis
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Fig. 2. Mean values for Na influx through the
Na/H antiport at six levels of internal pH in
red blood cells from control and dialysis
subjects. Measurements were taken at
external pH values of 6.0 and 8.0, and the
difference (pH0) represents the Na/H
exchange rate. Symbols are: (0) pH0 8.0; (•)
ApH0; (0) pH 6.0.
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end-stage renal failure requiring hemodialysis treatments. Ad-
ditional study will be required to elucidate the mechanism by
which the abundance of NHE- 1 is increased and the clinical
significance of the increased activity of this transport protein.
As indicated above, increased Na/H exchange has not previ-
ously been reported in red blood cells from uremic patients. An
increase in Na/H antiporter has been well documented, how-
ever, in experimental models of chronic metabolic acidosis with
[211 and without renal failure [22]. A number of prior studies,
however, have measured Na/Li countertransport in similar
populations of patients [2, 3, 23, 24]. In renal brush border
membrane vesicles, Na/Li countertransport is believed to be an
operative mode of the Na/H exchanger [20]. This may also be
true in some other tissues such as vascular smooth muscle [25].
It is not been confirmed, however, that Na exchange for H and
Na exchange for Li represents the operation of the same
transport protein in all tissues. It is probable that the NHE-l
form of the Na/H antiporter present in red blood cells is not the
same protein as the renal brush border membrane Na/H an-
tiporter. Canessa, Morgan and Semplicini [26] provided evi-
dence that Na/Li countertransport could be a mode of operation
of the Na/H antiporter in human red blood cells. Jennings,
Adams-Lackey and Cook, on the other hand, were unable to
demonstrate proton transport by the Na/Li countertransport
pathway in rabbit erythrocytes [27]. We previously reported
that there was no difference in Na/Li countertransport activity
in red blood cells between a similar population of dialysis
patients as in the present study and normal subjects [2]. These
studies, when considered in conjunction with the results of the
present experiments, suggest that Na/Li countertransport mea-
surements may not be a valid surrogate marker for the Na/H
exchanger in red blood cells from uremic patients. It might be
suggested that elucidation of the relation between Na/H and
Na/Li antiporters will require an understanding of the structure!
function relations of the NHE family of related transporters.
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